… ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference … announced details about upcoming presentations and an investor & analyst event at the North American Cystic …
Submitted CTA for lead program AX-0810, targeting NTCP for cholestatic diseasesAdvancing AX-2402 program toward clinical candidate selection, targeting MECP2 (R270X) for Rett SyndromeHosting fall Analyst and Investor Event (virtual), featuring detailed AX-0810 P
… program to enter the clinic Company to host virtual Investor and Analyst Event in December to highlight translational data and … diseases. ProQR will hold a virtual Analyst and InvestorEvent in December to highlight translational …
